Tuesday, March 24, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

A conversation with Ashley, an advocate with lived experience

Ashley Rodgers is a mother, wife and former healthcare worker. Additionally, she is a chronic pain patient of almost 30 years, who has been initiating legislative efforts to protect people in pain and their providers on both the state and national levels since the 2016 CDC Guidelines interrupted her pain management treatment in 2017.

#opioids #CDC #DEA

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. Judith says:

    Can confirm the broken bones bit! End of Feb. I broke my foot and had a severe sprain and it took three separate visits to three separate doctors in order to get any pain control outside of Tylenol. The first doctor at the urgent care that I visited because they had an x-ray machine and because this didn’t feel like an ER emergency, told me I had a teeny, tiny stress fracture and a moderate sprain, and then in the very next breath told me they do not prescribe narcotics per policy. I did not once bring up pain management.
    I tried to then, now that I “knew” what was going on with my foot and ankle, to make an appointment with my primary care doctor (he does not have an x-ray machine). The only issues were one, he was overseas, and two, he had put a blanket ban on prescribing opioid pain medication for his entire practice (still plan on meeting him face-to-face so he can explain this to me). I agreed to see the doctor that was filling in for him because I needed something. That doctor was very nice, he got me a sleep aid (didn’t do much) and tried getting me this Asprin based medication that I don’t even remember the name of because my insurance company refused to pay for it and it would have cost well over $700 out-of-pocket. I declined.
    I ended up making an appointment with an ortho who I had originally planned on not seeing because I was told I had a teeny, tiny stress fracture, and a moderate sprain. Turns out that the stress fracture was a full break, mid-point, with bone displacement, and the moderate sprain was rather severe with shredded ligaments (namely the ATFL and there are some issues with the tendons running up the inside of the ankle). I am still waiting to see if it’s going to require surgery to correct it (I feel that it is). The orthopedic gave me pain medication thankfully which I took for two weeks and miraculously didn’t develop SUDs.
    I fully, to the marrow of my bones believe that the urgent care doctor was more concerned about the question of pain management coming up than she was about the injury itself, she purposely played down the injury, and she did misrepresent the narrative in my charts.
    The whole affair was rather traumatizing, and it put me, the patient at substantial risk of having to go begging from doctor to doctor. The orthopedic could have said no to my request for stronger pain control and could have written “drug seeker” in my charts. That happens far too often for it not to be a concern.

  2. Candi says:

    Thank you Mr. Joshi & Ashley!!! Thank you for getting Mr. Joshi, Red & yourself on a call with Congressman/woman Boyles. Wtg! Thank you for ALL & Everything you’ve done & are doing to try to bring change & adequate care back for the pain community!!! I honestly don’t know how you do it all. But I am SOOOO grateful & thankful to you for everything you’re doing!!!!
    Thank you SOOO VERY much again from the bottom of my heart!!!!!

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!